Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
ServiceNow
NOW
|
$1.13B |
| 2 |
Meta Platforms (Facebook)
META
|
$1.12B |
| 3 |
Advanced Micro Devices
AMD
|
$1.06B |
| 4 |
MongoDB
MDB
|
$817M |
| 5 |
Ulta Beauty
ULTA
|
$477M |
Top Sells
| 1 |
Danaher
DHR
|
$1.27B |
| 2 |
T-Mobile US
TMUS
|
$1.03B |
| 3 |
Schlumberger
SLB
|
$964M |
| 4 |
Thermo Fisher Scientific
TMO
|
$829M |
| 5 |
Atlassian
TEAM
|
$819M |
Sector Composition
| 1 | Technology | 38.76% |
| 2 | Consumer Discretionary | 19.8% |
| 3 | Healthcare | 13.64% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Krystal Biotech
KRYS
$4.22B
| $6.84M | 0.01% |
+58,266
| New | +$6.84M |
|
402
TFI International
TFII
$7.92B
| $6.83M | 0.01% |
59,952
-644
| -1% | -$73.4K |
|
403
McCormick & Company Non-Voting
MKC
$18.8B
| $6.8M | 0.01% |
+77,955
| New | +$6.8M |
|
404
Service Corp International
SCI
$11B
| $6.72M | 0.01% |
104,039
+15,559
| +18% | +$1M |
|
405
Seres Therapeutics
MCRB
$211M
| $6.67M | 0.01% |
69,618
+36,381
| +109% | +$3.49M |
|
406
Xylem
XYL
$34B
| $6.67M | 0.01% |
59,204
| – | – |
|
407
CF Industries
CF
$13.6B
| $6.67M | 0.01% |
96,027
-27,429
| -22% | -$1.9M |
|
408
iShares Russell 1000 Growth ETF
IWF
$118B
| $6.53M | 0.01% |
23,718
-12,541
| -35% | -$3.45M |
|
|
AAT
409
American Assets Trust
AAT
$1.27B
| $6.48M | 0.01% |
337,516
-109,136
| -24% | -$2.1M |
|
410
TC Energy
TRP
$53.8B
| $6.42M | 0.01% |
158,813
-24,517
| -13% | -$991K |
|
411
EQT Corp
EQT
$31.8B
| $6.31M | 0.01% |
153,529
-1,265
| -0.8% | -$52K |
|
412
Mineralys Therapeutics
MLYS
$2.78B
| $6.06M | 0.01% |
355,475
| – | – |
|
413
KKR & Co
KKR
$123B
| $6.05M | 0.01% |
108,061
-26,395
| -20% | -$1.48M |
|
|
LTHM
414
DELISTED
Livent Corporation
LTHM
| $5.87M | ﹤0.01% |
214,027
-5,440
| -2% | -$149K |
|
415
General Mills
GIS
$26.7B
| $5.75M | ﹤0.01% |
74,965
+3,907
| +5% | +$300K |
|
|
NVRO
416
DELISTED
NEVRO CORP.
NVRO
| $5.53M | ﹤0.01% |
217,705
+9,090
| +4% | +$231K |
|
|
MAG
417
DELISTED
MAG Silver
MAG
| $5.5M | ﹤0.01% |
493,626
-951
| -0.2% | -$10.6K |
|
418
Kinder Morgan
KMI
$58.8B
| $5.45M | ﹤0.01% |
316,638
-154,425
| -33% | -$2.66M |
|
419
Toro Company
TTC
$7.91B
| $5.44M | ﹤0.01% |
53,548
+49,743
| +1,307% | +$5.06M |
|
420
Plains All American Pipeline
PAA
$12.1B
| $5.43M | ﹤0.01% |
385,282
-2,514
| -0.6% | -$35.4K |
|
421
Hudbay
HBM
$5.23B
| $5.36M | ﹤0.01% |
1,117,766
-1,879
| -0.2% | -$9.01K |
|
422
IBM
IBM
$237B
| $5.2M | ﹤0.01% |
38,825
-89,628
| -70% | -$12M |
|
423
Diageo
DEO
$59.2B
| $5.04M | ﹤0.01% |
29,074
-281
| -1% | -$48.7K |
|
|
CTLT
424
DELISTED
CATALENT, INC.
CTLT
| $4.86M | ﹤0.01% |
112,059
-11
| -0% | -$477 |
|
425
Vesta Real Estate
VTMX
$2.39B
| $4.83M | ﹤0.01% |
+150,000
| New | +$4.83M |
|